- Home
- UBCP vs AVTX Comparison
UBCP vs AVTX Comparison
Compare UBCP & AVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UBCP
- AVTX
- Stock Information
- Founded
- UBCP 1902
- AVTX 2011
- Country
- UBCP United States
- AVTX United States
- Employees
- UBCP N/A
- AVTX N/A
- Industry
- UBCP Major Banks
- AVTX Biotechnology: Pharmaceutical Preparations
- Sector
- UBCP Finance
- AVTX Health Care
- Exchange
- UBCP Nasdaq
- AVTX Nasdaq
- Market Cap
- UBCP 77.3M
- AVTX 90.9M
- IPO Year
- UBCP N/A
- AVTX 2015
- Fundamental
- Price
- UBCP $12.84
- AVTX $12.58
- Analyst Decision
- UBCP
- AVTX Buy
- Analyst Count
- UBCP 0
- AVTX 2
- Target Price
- UBCP N/A
- AVTX $35.00
- AVG Volume (30 Days)
- UBCP 6.9K
- AVTX 64.4K
- Earning Date
- UBCP 11-06-2024
- AVTX 11-07-2024
- Dividend Yield
- UBCP 5.54%
- AVTX N/A
- EPS Growth
- UBCP N/A
- AVTX N/A
- EPS
- UBCP 1.36
- AVTX N/A
- Revenue
- UBCP $29,229,619.00
- AVTX $820,000.00
- Revenue This Year
- UBCP N/A
- AVTX N/A
- Revenue Next Year
- UBCP $8.94
- AVTX N/A
- P/E Ratio
- UBCP $9.42
- AVTX N/A
- Revenue Growth
- UBCP N/A
- AVTX N/A
- 52 Week Low
- UBCP $10.38
- AVTX $3.95
- 52 Week High
- UBCP $15.50
- AVTX $34.46
- Technical
- Relative Strength Index (RSI)
- UBCP 48.94
- AVTX 52.17
- Support Level
- UBCP $12.03
- AVTX $12.00
- Resistance Level
- UBCP $13.05
- AVTX $13.59
- Average True Range (ATR)
- UBCP 0.39
- AVTX 0.96
- MACD
- UBCP -0.05
- AVTX -0.15
- Stochastic Oscillator
- UBCP 59.44
- AVTX 33.52
About UBCP United Bancorp Inc.
United Bancorp Inc operates as a bank holding company that provides commercial and retail banking services. The company's primary deposit products are checking, savings and term certificate accounts and its primary lending products are residential mortgages, commercial and installment loans. The company serves customers mainly located in Athens, Belmont, Carroll, Fairfield, Harrison, Jefferson and Tuscarawas Counties in Ohio and Marshall and Ohio Counties in West Virginia and the surrounding localities in northeastern, east-central and southeastern Ohio and include a wide range of individuals, businesses and other organizations.
About AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical stage biotechnology company focused on the treatment of immune dysregulation. The company's lead asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).